News Conference News ACC 2026 Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate Todd Neale April 02, 2026
News Conference News ACC 2026 Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI Yael L. Maxwell March 30, 2026
News Conference News ACC 2026 SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF Todd Neale March 29, 2026
News Conference News ACC 2026 ORBITA-CTO: PCI Reduces Angina Symptoms in Sham-Controlled Trial Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Noninvasive FFR Measures Match Wire-Based Assessment: ALL RISE and FAST III L.A. McKeown March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Conference News ACC 2025 Cardiologists Plot Next Moves After New Board Rejected Yael L. Maxwell April 11, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints L.A. McKeown April 03, 2025
News Conference News ACC 2025 Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE Caitlin E. Cox April 02, 2025
News Conference News ACC 2025 More ALIGN-AR Data Bolster Potential for a Dedicated AR Device Yael L. Maxwell March 30, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025